ANG Lifesciences Reports Q2 FY27 Loss; Auditor Highlights Loan Defaults and Unpaid Dues
ANG Lifesciences India Ltd · Financial Result · 15 Nov 2026, 3:00 am
ANG Lifesciences Reports Q2 FY27 Loss; Auditor Highlights Loan Defaults and Unpaid Dues ANG Lifesciences India reported a consolidated net loss of ₹208.85 lakh for Q2 ended 30th Sep'26, compared to a net loss of ₹294.73 lakh in Q2 ended 30th Sep'25, with revenue from operations declining 22.8% YoY to ₹2,010.03 lakh. For H1 ended 30th Sep'26, consolidated net loss expanded to ₹633.27 lakh on revenue of ₹3,539.80 lakh. Statutory auditors issued an unmodified opinion with Emphasis of Matter detailing ₹494.08 lakh in HDFC Bank loan defaults and unpaid statutory dues of ₹438.88 lakh.
Original exchange filing (PDF)
More announcements from ANG Lifesciences India Ltd
- Appointment of Mrs. Preeti Sarin as Additional Independent Director of the Company · 15 Nov 2026
- Approval of Unaudited Financial Results for the quarter and half year ended 30-09-2026. · 15 Nov 2026
- ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Unaudited Financial .... · 14 Nov 2026
- Scrutinizer''s Report for AGM along with Voting Results · 01 Oct 2026
- Re-appointment of Ms. Chetna as the Independent Director of the company. · 30 Sept 2026
- Proceedings of 20th Annual General Meeting are enclosed herewith. · 30 Sept 2026
- Pursuant to Regulations 30 and 34 of the SEBI (LODR) Regulations, 2015, as amended ('''' Listing Regulations''''), please find attached herewith the Annual Report of the Company for the .... · 08 Sept 2026
- Notice of 20th AGM · 08 Sept 2026
